

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.00789951 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.97084947 |
| 3 | purine nucleotide salvage (GO:0032261) | 4.95665934 |
| 4 | immunoglobulin mediated immune response (GO:0016064) | 4.92655080 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.66340746 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.66340746 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 4.66340746 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.66340746 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.66340746 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.66340746 |
| 11 | response to peptidoglycan (GO:0032494) | 4.63957729 |
| 12 | respiratory burst (GO:0045730) | 4.53823868 |
| 13 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.52824034 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 4.40829443 |
| 15 | granulocyte activation (GO:0036230) | 4.40828312 |
| 16 | positive regulation of interferon-alpha production (GO:0032727) | 4.38568617 |
| 17 | neutrophil activation (GO:0042119) | 4.35816694 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.35298835 |
| 19 | negative regulation of cell killing (GO:0031342) | 4.35298835 |
| 20 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.27061576 |
| 21 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.27061576 |
| 22 | regulation of plasminogen activation (GO:0010755) | 4.26879304 |
| 23 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.26071000 |
| 24 | homocysteine metabolic process (GO:0050667) | 4.20669222 |
| 25 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.11829482 |
| 26 | regulation of interferon-alpha production (GO:0032647) | 4.11828746 |
| 27 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.06672718 |
| 28 | cytidine metabolic process (GO:0046087) | 4.05199774 |
| 29 | cytidine catabolic process (GO:0006216) | 4.05199774 |
| 30 | cytidine deamination (GO:0009972) | 4.05199774 |
| 31 | cellular response to zinc ion (GO:0071294) | 4.04682071 |
| 32 | macrophage activation involved in immune response (GO:0002281) | 4.00860010 |
| 33 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.00195478 |
| 34 | B cell mediated immunity (GO:0019724) | 3.88690170 |
| 35 | adenosine metabolic process (GO:0046085) | 3.81519640 |
| 36 | positive regulation of antigen processing and presentation (GO:0002579) | 3.81265391 |
| 37 | sulfur amino acid catabolic process (GO:0000098) | 3.79209151 |
| 38 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.77814614 |
| 39 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.75674557 |
| 40 | type I interferon signaling pathway (GO:0060337) | 3.70016246 |
| 41 | cellular response to type I interferon (GO:0071357) | 3.70016246 |
| 42 | response to type I interferon (GO:0034340) | 3.66992765 |
| 43 | T-helper 1 type immune response (GO:0042088) | 3.65130680 |
| 44 | reactive oxygen species biosynthetic process (GO:1903409) | 3.64013035 |
| 45 | response to muramyl dipeptide (GO:0032495) | 3.61842071 |
| 46 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.60620229 |
| 47 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.57640083 |
| 48 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.57640083 |
| 49 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.57160765 |
| 50 | T cell migration (GO:0072678) | 3.56256520 |
| 51 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.54959406 |
| 52 | positive regulation of mast cell degranulation (GO:0043306) | 3.54959406 |
| 53 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.54449913 |
| 54 | myeloid cell activation involved in immune response (GO:0002275) | 3.52911236 |
| 55 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.52157465 |
| 56 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.51951831 |
| 57 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.50961610 |
| 58 | positive thymic T cell selection (GO:0045059) | 3.49244599 |
| 59 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.48643876 |
| 60 | superoxide anion generation (GO:0042554) | 3.47781306 |
| 61 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.47683635 |
| 62 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.46256964 |
| 63 | regulation of chronic inflammatory response (GO:0002676) | 3.46227428 |
| 64 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.44431657 |
| 65 | positive regulation of B cell differentiation (GO:0045579) | 3.43105930 |
| 66 | defense response to protozoan (GO:0042832) | 3.41201551 |
| 67 | regulation of vitamin metabolic process (GO:0030656) | 3.36809844 |
| 68 | response to interferon-beta (GO:0035456) | 3.34093990 |
| 69 | positive regulation of mast cell activation (GO:0033005) | 3.33651369 |
| 70 | myeloid dendritic cell differentiation (GO:0043011) | 3.33526636 |
| 71 | regulation of antigen processing and presentation (GO:0002577) | 3.30118998 |
| 72 | detection of molecule of bacterial origin (GO:0032490) | 3.28854976 |
| 73 | cellular extravasation (GO:0045123) | 3.27301025 |
| 74 | myeloid dendritic cell activation (GO:0001773) | 3.26920103 |
| 75 | natural killer cell mediated immunity (GO:0002228) | 3.24252644 |
| 76 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.24252644 |
| 77 | regulation of B cell differentiation (GO:0045577) | 3.24219627 |
| 78 | cellular response to interferon-beta (GO:0035458) | 3.23137774 |
| 79 | positive regulation of interferon-beta production (GO:0032728) | 3.21166465 |
| 80 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.20379140 |
| 81 | B cell receptor signaling pathway (GO:0050853) | 3.20136399 |
| 82 | positive regulation of humoral immune response (GO:0002922) | 3.19585151 |
| 83 | regulation of mast cell degranulation (GO:0043304) | 3.19476628 |
| 84 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.18141725 |
| 85 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.16743809 |
| 86 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.16667750 |
| 87 | regulation of T cell tolerance induction (GO:0002664) | 3.16067375 |
| 88 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.15476646 |
| 89 | chemokine-mediated signaling pathway (GO:0070098) | 3.14171256 |
| 90 | T cell costimulation (GO:0031295) | 3.13326490 |
| 91 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.12990086 |
| 92 | regulation of hypersensitivity (GO:0002883) | 3.12263214 |
| 93 | lymphocyte costimulation (GO:0031294) | 3.12066641 |
| 94 | cellular response to interleukin-15 (GO:0071350) | 3.10987400 |
| 95 | response to host immune response (GO:0052572) | 3.10759540 |
| 96 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.10759540 |
| 97 | microtubule nucleation (GO:0007020) | 3.10573730 |
| 98 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.10309732 |
| 99 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.10124430 |
| 100 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.09480522 |
| 101 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.09041837 |
| 102 | leukocyte mediated cytotoxicity (GO:0001909) | 3.08535172 |
| 103 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.08043845 |
| 104 | positive regulation of interleukin-12 production (GO:0032735) | 3.05518265 |
| 105 | macrophage activation (GO:0042116) | 3.05517532 |
| 106 | detection of bacterium (GO:0016045) | 3.05106937 |
| 107 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.04295465 |
| 108 | detection of other organism (GO:0098543) | 3.03715521 |
| 109 | lymphocyte mediated immunity (GO:0002449) | 3.03009710 |
| 110 | negative regulation of interleukin-17 production (GO:0032700) | 3.02674078 |
| 111 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.02293086 |
| 112 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.01292109 |
| 113 | leukocyte aggregation (GO:0070486) | 3.01204728 |
| 114 | response to protozoan (GO:0001562) | 3.01137511 |
| 115 | myeloid leukocyte activation (GO:0002274) | 2.99361529 |
| 116 | cysteine metabolic process (GO:0006534) | 2.98180221 |
| 117 | regulation of chemokine biosynthetic process (GO:0045073) | 2.98074689 |
| 118 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.97945248 |
| 119 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.97945248 |
| 120 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.97419922 |
| 121 | response to interferon-alpha (GO:0035455) | 2.97003406 |
| 122 | regulation of superoxide anion generation (GO:0032928) | 2.96386525 |
| 123 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.95178085 |
| 124 | nucleotide salvage (GO:0043173) | 2.94652931 |
| 125 | microglial cell activation (GO:0001774) | 2.94321651 |
| 126 | negative regulation of viral genome replication (GO:0045071) | 2.93978531 |
| 127 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.93823650 |
| 128 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.93399555 |
| 129 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.92966950 |
| 130 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.90093893 |
| 131 | positive regulation of B cell mediated immunity (GO:0002714) | 2.90093893 |
| 132 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.90058399 |
| 133 | regulation of mononuclear cell migration (GO:0071675) | 2.89705318 |
| 134 | negative regulation of interleukin-1 production (GO:0032692) | 2.89271657 |
| 135 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.89172029 |
| 136 | regulation of regulatory T cell differentiation (GO:0045589) | 2.88575236 |
| 137 | regulation of mast cell activation (GO:0033003) | 2.87987119 |
| 138 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.87817109 |
| 139 | interferon-gamma production (GO:0032609) | 2.87622525 |
| 140 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.87417274 |
| 141 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.86421814 |
| 142 | negative regulation of interleukin-12 production (GO:0032695) | 2.86242714 |
| 143 | cell migration involved in heart development (GO:0060973) | 2.85570491 |
| 144 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.84733532 |
| 145 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.84503797 |
| 146 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.83710919 |
| 147 | monocyte chemotaxis (GO:0002548) | 2.83272184 |
| 148 | dendritic cell differentiation (GO:0097028) | 2.82838794 |
| 149 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.82416629 |
| 150 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.82126094 |
| 151 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.81876660 |
| 152 | negative T cell selection (GO:0043383) | 2.81853314 |
| 153 | negative thymic T cell selection (GO:0045060) | 2.81080919 |
| 154 | T cell selection (GO:0045058) | 2.80884520 |
| 155 | response to interleukin-15 (GO:0070672) | 2.80485643 |
| 156 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.80219451 |
| 157 | NIK/NF-kappaB signaling (GO:0038061) | 2.79972854 |
| 158 | cellular response to interferon-gamma (GO:0071346) | 2.78329774 |
| 159 | DNA deamination (GO:0045006) | 2.78192483 |
| 160 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.77823042 |
| 161 | positive T cell selection (GO:0043368) | 2.77355555 |
| 162 | natural killer cell differentiation (GO:0001779) | 2.77203103 |
| 163 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.76834940 |
| 164 | cellular response to virus (GO:0098586) | 2.76747019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.57939917 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.79082274 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.37016701 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.92509120 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.39154603 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.19845993 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.05699756 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.02745628 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.79237566 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.58270912 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.36888816 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32843679 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.18868009 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.02642462 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.85612457 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.82249317 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.72065643 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.65007776 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.61599049 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.47238852 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.44003532 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.34759068 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.24939377 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.99143314 |
| 25 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.94986461 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.90537470 |
| 27 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.89377537 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86559537 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.86166757 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.82528318 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.79325514 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.73412512 |
| 33 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.71917957 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.71702187 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.70917253 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.70763752 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69798366 |
| 38 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64366732 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.63850012 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61608043 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60984429 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.54882068 |
| 43 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.54592892 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54267927 |
| 45 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53736563 |
| 46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47707107 |
| 47 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44232272 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41591636 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37602857 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35858934 |
| 51 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33892113 |
| 52 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32049710 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31312444 |
| 54 | MYC_22102868_ChIP-Seq_BL_Human | 1.27864802 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27666982 |
| 56 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25927404 |
| 57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25206010 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25036698 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21117939 |
| 60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.17636134 |
| 61 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.15987238 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14592843 |
| 63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11355833 |
| 64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11351946 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10814867 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10484359 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.08359251 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08045524 |
| 69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.07627170 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05635051 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04905331 |
| 72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01097802 |
| 73 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.00233807 |
| 74 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.00233807 |
| 75 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.00233807 |
| 76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98861760 |
| 77 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.97749808 |
| 78 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96606233 |
| 79 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96361504 |
| 80 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.95720382 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95012863 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93352934 |
| 83 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.92765289 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92054025 |
| 85 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.91483620 |
| 86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90563365 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90138559 |
| 88 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87450142 |
| 89 | P300_27268052_Chip-Seq_Bcells_Human | 0.85795322 |
| 90 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.84316981 |
| 91 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84272671 |
| 92 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.84179325 |
| 93 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83282155 |
| 94 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.82834983 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82568678 |
| 96 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82511230 |
| 97 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80993149 |
| 98 | GATA1_22025678_ChIP-Seq_K562_Human | 0.80964184 |
| 99 | GATA3_26560356_Chip-Seq_TH1_Human | 0.80606193 |
| 100 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.77955391 |
| 101 | P68_20966046_ChIP-Seq_HELA_Human | 0.77356888 |
| 102 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.77047317 |
| 103 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76998999 |
| 104 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.76137870 |
| 105 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75008147 |
| 106 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.74338790 |
| 107 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74204161 |
| 108 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73847787 |
| 109 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.73175473 |
| 110 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.72644249 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72156362 |
| 112 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.72088661 |
| 113 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.70897528 |
| 114 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.67814711 |
| 115 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.65513332 |
| 116 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.65240747 |
| 117 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.65175751 |
| 118 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.64065984 |
| 119 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.62339337 |
| 120 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.58901599 |
| 121 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58096058 |
| 122 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.57915642 |
| 123 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.57570568 |
| 124 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.57238239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.26794911 |
| 2 | MP0003436_decreased_susceptibility_to | 3.99089132 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.74198909 |
| 4 | MP0009785_altered_susceptibility_to | 3.72346831 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.24656041 |
| 6 | MP0001790_abnormal_immune_system | 3.17704871 |
| 7 | MP0005387_immune_system_phenotype | 3.17704871 |
| 8 | MP0000685_abnormal_immune_system | 3.16637170 |
| 9 | MP0005671_abnormal_response_to | 3.09866893 |
| 10 | MP0002419_abnormal_innate_immunity | 3.06952447 |
| 11 | MP0005025_abnormal_response_to | 3.04179588 |
| 12 | MP0003724_increased_susceptibility_to | 3.01124058 |
| 13 | MP0006082_CNS_inflammation | 2.92994143 |
| 14 | MP0001800_abnormal_humoral_immune | 2.85256336 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.84444467 |
| 16 | MP0002723_abnormal_immune_serum | 2.65652499 |
| 17 | MP0001819_abnormal_immune_cell | 2.45848785 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.43992946 |
| 19 | MP0004510_myositis | 2.41320387 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 2.40767898 |
| 21 | MP0003303_peritoneal_inflammation | 2.24060597 |
| 22 | MP0005360_urolithiasis | 2.18643949 |
| 23 | MP0003011_delayed_dark_adaptation | 2.08894667 |
| 24 | MP0005058_abnormal_lysosome_morphology | 2.00992343 |
| 25 | MP0002405_respiratory_system_inflammati | 1.99272500 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.98022065 |
| 27 | MP0001853_heart_inflammation | 1.96317698 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.94467855 |
| 29 | MP0002006_tumorigenesis | 1.92321929 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.85092842 |
| 31 | MP0000716_abnormal_immune_system | 1.84061612 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.79771046 |
| 33 | MP0009764_decreased_sensitivity_to | 1.78234068 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.76780960 |
| 35 | MP0002398_abnormal_bone_marrow | 1.76167725 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.72973692 |
| 37 | MP0004947_skin_inflammation | 1.64007650 |
| 38 | MP0005310_abnormal_salivary_gland | 1.63860974 |
| 39 | MP0008469_abnormal_protein_level | 1.62698348 |
| 40 | MP0005670_abnormal_white_adipose | 1.62565320 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.62501944 |
| 42 | MP0000343_altered_response_to | 1.54782004 |
| 43 | MP0003448_altered_tumor_morphology | 1.54586145 |
| 44 | MP0003075_altered_response_to | 1.52332336 |
| 45 | MP0002429_abnormal_blood_cell | 1.50159713 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 1.48153899 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.47243454 |
| 48 | MP0002722_abnormal_immune_system | 1.39391727 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.36232522 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.30842374 |
| 51 | MP0000858_altered_metastatic_potential | 1.30168646 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.28386734 |
| 53 | MP0002254_reproductive_system_inflammat | 1.28374236 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.28054747 |
| 55 | MP0003866_abnormal_defecation | 1.26721491 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.25843667 |
| 57 | MP0002139_abnormal_hepatobiliary_system | 1.11663492 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.11504606 |
| 59 | MP0008995_early_reproductive_senescence | 1.11412574 |
| 60 | MP0005646_abnormal_pituitary_gland | 1.11376836 |
| 61 | MP0003828_pulmonary_edema | 1.11303984 |
| 62 | MP0009278_abnormal_bone_marrow | 1.10147953 |
| 63 | MP0005166_decreased_susceptibility_to | 1.09509849 |
| 64 | MP0003763_abnormal_thymus_physiology | 1.09465629 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 1.08829002 |
| 66 | MP0001661_extended_life_span | 1.08712221 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.07985660 |
| 68 | MP0001545_abnormal_hematopoietic_system | 1.07985660 |
| 69 | MP0001764_abnormal_homeostasis | 1.02131551 |
| 70 | MP0002396_abnormal_hematopoietic_system | 1.02047712 |
| 71 | MP0002163_abnormal_gland_morphology | 1.00072178 |
| 72 | MP0003186_abnormal_redox_activity | 0.98263813 |
| 73 | MP0001879_abnormal_lymphatic_vessel | 0.96932792 |
| 74 | MP0005390_skeleton_phenotype | 0.96910091 |
| 75 | MP0009840_abnormal_foam_cell | 0.96306698 |
| 76 | MP0002933_joint_inflammation | 0.95751301 |
| 77 | MP0000013_abnormal_adipose_tissue | 0.95130308 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 0.92670490 |
| 79 | MP0005451_abnormal_body_composition | 0.90503576 |
| 80 | MP0009763_increased_sensitivity_to | 0.90008155 |
| 81 | MP0000249_abnormal_blood_vessel | 0.88772844 |
| 82 | MP0001851_eye_inflammation | 0.88020694 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 0.87658494 |
| 84 | MP0005253_abnormal_eye_physiology | 0.86740297 |
| 85 | MP0005076_abnormal_cell_differentiation | 0.85025490 |
| 86 | MP0006292_abnormal_olfactory_placode | 0.80488740 |
| 87 | MP0000767_abnormal_smooth_muscle | 0.80338501 |
| 88 | MP0000371_diluted_coat_color | 0.79738769 |
| 89 | MP0005164_abnormal_response_to | 0.77965654 |
| 90 | MP0000703_abnormal_thymus_morphology | 0.75452217 |
| 91 | MP0002090_abnormal_vision | 0.75409652 |
| 92 | MP0003183_abnormal_peptide_metabolism | 0.75391044 |
| 93 | MP0000490_abnormal_crypts_of | 0.75091126 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.74714672 |
| 95 | MP0001663_abnormal_digestive_system | 0.72995894 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.72841313 |
| 97 | MP0000516_abnormal_urinary_system | 0.70706416 |
| 98 | MP0005367_renal/urinary_system_phenotyp | 0.70706416 |
| 99 | MP0009643_abnormal_urine_homeostasis | 0.70266703 |
| 100 | MP0001324_abnormal_eye_pigmentation | 0.69983274 |
| 101 | MP0001873_stomach_inflammation | 0.69513105 |
| 102 | MP0002095_abnormal_skin_pigmentation | 0.69404219 |
| 103 | MP0001348_abnormal_lacrimal_gland | 0.69076178 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.68622503 |
| 105 | MP0005174_abnormal_tail_pigmentation | 0.66368138 |
| 106 | MP0002693_abnormal_pancreas_physiology | 0.65449793 |
| 107 | MP0005165_increased_susceptibility_to | 0.64189681 |
| 108 | MP0003300_gastrointestinal_ulcer | 0.62942059 |
| 109 | MP0005376_homeostasis/metabolism_phenot | 0.60989538 |
| 110 | MP0002132_abnormal_respiratory_system | 0.60180055 |
| 111 | MP0000604_amyloidosis | 0.59991458 |
| 112 | MP0004883_abnormal_blood_vessel | 0.59882414 |
| 113 | MP0000920_abnormal_myelination | 0.59078075 |
| 114 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58842541 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.58450671 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.58193882 |
| 117 | MP0003795_abnormal_bone_structure | 0.57433994 |
| 118 | MP0004130_abnormal_muscle_cell | 0.56466046 |
| 119 | MP0004885_abnormal_endolymph | 0.55351230 |
| 120 | MP0010307_abnormal_tumor_latency | 0.54658558 |
| 121 | MP0003045_fibrosis | 0.54648424 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.54112790 |
| 123 | MP0008873_increased_physiological_sensi | 0.53810384 |
| 124 | MP0002877_abnormal_melanocyte_morpholog | 0.53650316 |
| 125 | MP0002019_abnormal_tumor_incidence | 0.53345111 |
| 126 | MP0004381_abnormal_hair_follicle | 0.53330410 |
| 127 | MP0010368_abnormal_lymphatic_system | 0.52958911 |
| 128 | MP0003690_abnormal_glial_cell | 0.52239070 |
| 129 | MP0010352_gastrointestinal_tract_polyps | 0.51376525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.00379058 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.61970577 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.45717591 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.96939266 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 4.94123870 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.80534781 |
| 7 | Constricted visual fields (HP:0001133) | 4.54663680 |
| 8 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.51911292 |
| 9 | Abnormality of alanine metabolism (HP:0010916) | 4.51911292 |
| 10 | Hyperalaninemia (HP:0003348) | 4.51911292 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.46804256 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.42691666 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.40864629 |
| 14 | Recurrent skin infections (HP:0001581) | 4.14715528 |
| 15 | Myositis (HP:0100614) | 4.08418818 |
| 16 | Recurrent fungal infections (HP:0002841) | 4.07319144 |
| 17 | Anorexia (HP:0002039) | 4.06300196 |
| 18 | Pulmonary embolism (HP:0002204) | 3.97112046 |
| 19 | Orchitis (HP:0100796) | 3.95590468 |
| 20 | Increased IgM level (HP:0003496) | 3.94569237 |
| 21 | Gingivitis (HP:0000230) | 3.93035959 |
| 22 | Esophageal varix (HP:0002040) | 3.91094677 |
| 23 | Cellulitis (HP:0100658) | 3.69295736 |
| 24 | Recurrent viral infections (HP:0004429) | 3.53605592 |
| 25 | Vacuolated lymphocytes (HP:0001922) | 3.53335281 |
| 26 | Vasculitis (HP:0002633) | 3.52033196 |
| 27 | Myocardial infarction (HP:0001658) | 3.51137507 |
| 28 | Obstructive lung disease (HP:0006536) | 3.45020806 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 3.45020806 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 3.42355829 |
| 31 | Optic neuritis (HP:0100653) | 3.42355829 |
| 32 | Conjunctival telangiectasia (HP:0000524) | 3.38332141 |
| 33 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.31407032 |
| 34 | Pigmentary retinal degeneration (HP:0001146) | 3.30936614 |
| 35 | Interstitial pulmonary disease (HP:0006530) | 3.28421539 |
| 36 | Dyschromatopsia (HP:0007641) | 3.25043505 |
| 37 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.23921556 |
| 38 | Congenital sensorineural hearing impairment (HP:0008527) | 3.21712162 |
| 39 | Recurrent cutaneous fungal infections (HP:0011370) | 3.15623265 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.15623265 |
| 41 | Axonal loss (HP:0003447) | 3.04147539 |
| 42 | Meningitis (HP:0001287) | 3.02658421 |
| 43 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.00995285 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.00366219 |
| 45 | Thrombophlebitis (HP:0004418) | 2.92687903 |
| 46 | Increased cerebral lipofuscin (HP:0011813) | 2.89135333 |
| 47 | Glomerulonephritis (HP:0000099) | 2.87293113 |
| 48 | Recurrent pneumonia (HP:0006532) | 2.86350245 |
| 49 | Fatigue (HP:0012378) | 2.86270967 |
| 50 | Urticaria (HP:0001025) | 2.85629368 |
| 51 | Agammaglobulinemia (HP:0004432) | 2.81786377 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.77462843 |
| 53 | Basal ganglia calcification (HP:0002135) | 2.75945799 |
| 54 | Periodontitis (HP:0000704) | 2.74834580 |
| 55 | Pustule (HP:0200039) | 2.70724608 |
| 56 | Pendular nystagmus (HP:0012043) | 2.69605673 |
| 57 | Leukocytosis (HP:0001974) | 2.63864398 |
| 58 | Recurrent lower respiratory tract infections (HP:0002783) | 2.61037068 |
| 59 | Epistaxis (HP:0000421) | 2.57413530 |
| 60 | IgG deficiency (HP:0004315) | 2.55708653 |
| 61 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.55652210 |
| 62 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.55652210 |
| 63 | Abnormality of glycolipid metabolism (HP:0010969) | 2.55652210 |
| 64 | Encephalitis (HP:0002383) | 2.55316681 |
| 65 | Granulocytopenia (HP:0001913) | 2.54914013 |
| 66 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.54283358 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.53285957 |
| 68 | Disinhibition (HP:0000734) | 2.53129134 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.53023848 |
| 70 | Stomatitis (HP:0010280) | 2.52364017 |
| 71 | Colitis (HP:0002583) | 2.52235094 |
| 72 | Gangrene (HP:0100758) | 2.51930786 |
| 73 | Congenital stationary night blindness (HP:0007642) | 2.50628565 |
| 74 | Chronic diarrhea (HP:0002028) | 2.50035835 |
| 75 | Osteomyelitis (HP:0002754) | 2.49159426 |
| 76 | Abnormality of T cell number (HP:0011839) | 2.47994120 |
| 77 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.46555386 |
| 78 | Abolished electroretinogram (ERG) (HP:0000550) | 2.44394766 |
| 79 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.43645483 |
| 80 | Chest pain (HP:0100749) | 2.43503983 |
| 81 | Restrictive lung disease (HP:0002091) | 2.43395336 |
| 82 | Progressive visual loss (HP:0000529) | 2.42933414 |
| 83 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.40125116 |
| 84 | Petechiae (HP:0000967) | 2.38647993 |
| 85 | Thyroiditis (HP:0100646) | 2.36908505 |
| 86 | Gingival bleeding (HP:0000225) | 2.36856542 |
| 87 | White forelock (HP:0002211) | 2.36641975 |
| 88 | Combined immunodeficiency (HP:0005387) | 2.36565921 |
| 89 | Hemoptysis (HP:0002105) | 2.35349221 |
| 90 | Chronic otitis media (HP:0000389) | 2.32875034 |
| 91 | Lymphopenia (HP:0001888) | 2.31667473 |
| 92 | Inflammation of the large intestine (HP:0002037) | 2.30031213 |
| 93 | Abnormality of the nasal mucosa (HP:0000433) | 2.29674798 |
| 94 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.29228028 |
| 95 | Single umbilical artery (HP:0001195) | 2.29228028 |
| 96 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.29228028 |
| 97 | Nasal polyposis (HP:0100582) | 2.26918697 |
| 98 | Homocystinuria (HP:0002156) | 2.26841037 |
| 99 | Abnormality of homocysteine metabolism (HP:0010919) | 2.26841037 |
| 100 | Arterial thrombosis (HP:0004420) | 2.26243393 |
| 101 | Recurrent bronchitis (HP:0002837) | 2.24919069 |
| 102 | IgM deficiency (HP:0002850) | 2.24273196 |
| 103 | Nausea (HP:0002018) | 2.22543217 |
| 104 | Cerebral ischemia (HP:0002637) | 2.20453709 |
| 105 | Autoimmune hemolytic anemia (HP:0001890) | 2.19419869 |
| 106 | Poor speech (HP:0002465) | 2.19252330 |
| 107 | Eosinophilia (HP:0001880) | 2.18719123 |
| 108 | Abnormality of eosinophils (HP:0001879) | 2.17143990 |
| 109 | Hematochezia (HP:0002573) | 2.16352140 |
| 110 | Hypertensive crisis (HP:0100735) | 2.16086507 |
| 111 | Gastrointestinal stroma tumor (HP:0100723) | 2.15761742 |
| 112 | Keratoconjunctivitis sicca (HP:0001097) | 2.14842748 |
| 113 | Abnormality of T cells (HP:0002843) | 2.14424114 |
| 114 | Patchy hypopigmentation of hair (HP:0011365) | 2.14328089 |
| 115 | Tetraparesis (HP:0002273) | 2.14128126 |
| 116 | Gastrointestinal inflammation (HP:0004386) | 2.13878992 |
| 117 | Chronic sinusitis (HP:0011109) | 2.12825643 |
| 118 | Thick nail (HP:0001805) | 2.12578707 |
| 119 | Purpura (HP:0000979) | 2.12399359 |
| 120 | Gastrointestinal infarctions (HP:0005244) | 2.10888949 |
| 121 | Prostate neoplasm (HP:0100787) | 2.10670761 |
| 122 | Polyneuropathy (HP:0001271) | 2.09671978 |
| 123 | Mucosal telangiectasiae (HP:0100579) | 2.09641473 |
| 124 | Sepsis (HP:0100806) | 2.09568114 |
| 125 | Chorioretinal atrophy (HP:0000533) | 2.09550493 |
| 126 | Abnormality of T cell physiology (HP:0011840) | 2.08944792 |
| 127 | Dysostosis multiplex (HP:0000943) | 2.08569062 |
| 128 | Leukopenia (HP:0001882) | 2.08184525 |
| 129 | Recurrent sinusitis (HP:0011108) | 2.08033170 |
| 130 | Microcytic anemia (HP:0001935) | 2.07269066 |
| 131 | T lymphocytopenia (HP:0005403) | 2.07217150 |
| 132 | Poor head control (HP:0002421) | 2.06398684 |
| 133 | Agnosia (HP:0010524) | 2.06175956 |
| 134 | Generalized aminoaciduria (HP:0002909) | 2.05520532 |
| 135 | Abnormality of the prostate (HP:0008775) | 2.04240852 |
| 136 | Macular degeneration (HP:0000608) | 2.04240393 |
| 137 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01543135 |
| 138 | Cheilitis (HP:0100825) | 2.01405376 |
| 139 | Loss of speech (HP:0002371) | 2.01268779 |
| 140 | Panhypogammaglobulinemia (HP:0003139) | 2.01242392 |
| 141 | Hypochromic anemia (HP:0001931) | 2.00135860 |
| 142 | Upper motor neuron abnormality (HP:0002127) | 1.97186499 |
| 143 | Abnormality of the pleura (HP:0002103) | 1.96113801 |
| 144 | Nephritis (HP:0000123) | 1.95905977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.27944017 |
| 2 | MAP3K3 | 3.55973152 |
| 3 | RIPK4 | 3.44022423 |
| 4 | MAP4K1 | 3.31464840 |
| 5 | TBK1 | 3.11760578 |
| 6 | BLK | 3.09690859 |
| 7 | TYK2 | 2.92842689 |
| 8 | ERN1 | 2.81341151 |
| 9 | IRAK4 | 2.73155894 |
| 10 | IKBKB | 2.60071124 |
| 11 | IKBKE | 2.49776521 |
| 12 | TGFBR2 | 2.41349543 |
| 13 | PBK | 2.28980050 |
| 14 | TXK | 2.25572899 |
| 15 | JAK3 | 2.19093919 |
| 16 | IRAK3 | 2.09601138 |
| 17 | CSF1R | 2.05139574 |
| 18 | KIT | 1.99267893 |
| 19 | PIM2 | 1.92162811 |
| 20 | JAK1 | 1.84712557 |
| 21 | CSK | 1.74042726 |
| 22 | CDK9 | 1.72506983 |
| 23 | ZAP70 | 1.68721672 |
| 24 | SYK | 1.67528024 |
| 25 | CHUK | 1.64848176 |
| 26 | ACVR1B | 1.64655974 |
| 27 | GRK1 | 1.64392784 |
| 28 | MAP3K13 | 1.64162846 |
| 29 | TESK2 | 1.51868545 |
| 30 | CDK12 | 1.47935089 |
| 31 | BTK | 1.40802697 |
| 32 | HCK | 1.37307583 |
| 33 | FGFR3 | 1.33850080 |
| 34 | GRK7 | 1.29396309 |
| 35 | PRPF4B | 1.28734324 |
| 36 | LYN | 1.27905426 |
| 37 | TEC | 1.25325933 |
| 38 | PIM1 | 1.23677696 |
| 39 | GRK6 | 1.21933573 |
| 40 | STK10 | 1.21053103 |
| 41 | ADRBK2 | 1.18063867 |
| 42 | KDR | 1.16544793 |
| 43 | LCK | 1.12865492 |
| 44 | RPS6KA4 | 1.11413559 |
| 45 | CDK19 | 1.08499466 |
| 46 | MAP3K10 | 1.07142190 |
| 47 | BMPR2 | 1.07032693 |
| 48 | MST4 | 1.05232592 |
| 49 | MATK | 1.05016104 |
| 50 | TNK2 | 1.04307666 |
| 51 | RPS6KB2 | 1.03287807 |
| 52 | JAK2 | 0.95657750 |
| 53 | CCNB1 | 0.93019902 |
| 54 | PASK | 0.90530456 |
| 55 | CLK1 | 0.88785758 |
| 56 | ABL2 | 0.88751355 |
| 57 | EIF2AK2 | 0.88523553 |
| 58 | MARK3 | 0.87959195 |
| 59 | STK4 | 0.87117045 |
| 60 | NEK9 | 0.86520646 |
| 61 | BMX | 0.85127608 |
| 62 | FLT3 | 0.83513494 |
| 63 | ITK | 0.83425316 |
| 64 | FES | 0.81374628 |
| 65 | EIF2AK3 | 0.81006775 |
| 66 | IRAK2 | 0.80679596 |
| 67 | NME2 | 0.78955501 |
| 68 | CAMKK2 | 0.76002347 |
| 69 | PRKCD | 0.75555913 |
| 70 | MST1R | 0.74330953 |
| 71 | FGR | 0.73665942 |
| 72 | NTRK2 | 0.73154319 |
| 73 | FGFR4 | 0.73060874 |
| 74 | TAOK3 | 0.72878910 |
| 75 | SGK494 | 0.72588134 |
| 76 | SGK223 | 0.72588134 |
| 77 | MAPK7 | 0.72260845 |
| 78 | GRK5 | 0.71317337 |
| 79 | ARAF | 0.69971535 |
| 80 | SIK2 | 0.68600266 |
| 81 | TAOK2 | 0.68421563 |
| 82 | SGK2 | 0.68276246 |
| 83 | YES1 | 0.67085405 |
| 84 | LRRK2 | 0.66815720 |
| 85 | CAMK1D | 0.65089120 |
| 86 | TIE1 | 0.63665872 |
| 87 | PKN2 | 0.62243865 |
| 88 | MAPK12 | 0.60829386 |
| 89 | CDK4 | 0.60499712 |
| 90 | EPHB1 | 0.60209421 |
| 91 | MOS | 0.59662393 |
| 92 | CAMKK1 | 0.58693545 |
| 93 | EGFR | 0.58402865 |
| 94 | MAP2K3 | 0.58110514 |
| 95 | ABL1 | 0.57205642 |
| 96 | TYRO3 | 0.55207207 |
| 97 | SIK1 | 0.53624239 |
| 98 | SIK3 | 0.51873599 |
| 99 | MAPKAPK2 | 0.50816335 |
| 100 | MAP3K11 | 0.50722541 |
| 101 | RIPK1 | 0.49846957 |
| 102 | TLK1 | 0.48405065 |
| 103 | PRKCQ | 0.48363510 |
| 104 | PRKG2 | 0.45208174 |
| 105 | SGK3 | 0.44584208 |
| 106 | SMG1 | 0.41955659 |
| 107 | IGF1R | 0.40859499 |
| 108 | STK3 | 0.40057325 |
| 109 | AURKA | 0.37814000 |
| 110 | ADRBK1 | 0.37327843 |
| 111 | PRKCH | 0.36625677 |
| 112 | STK24 | 0.36589422 |
| 113 | TAOK1 | 0.36207480 |
| 114 | PAK4 | 0.34974002 |
| 115 | CDC42BPA | 0.32790566 |
| 116 | MAP3K1 | 0.32326812 |
| 117 | RPS6KA6 | 0.31525650 |
| 118 | TGFBR1 | 0.30833579 |
| 119 | MAP3K8 | 0.29569631 |
| 120 | NEK6 | 0.29154053 |
| 121 | INSR | 0.28429770 |
| 122 | CDK6 | 0.27997535 |
| 123 | FYN | 0.27132683 |
| 124 | PTK6 | 0.26927548 |
| 125 | CSNK1A1 | 0.26182418 |
| 126 | ERBB3 | 0.26102209 |
| 127 | PAK1 | 0.25587819 |
| 128 | PDK1 | 0.25289488 |
| 129 | MAPK4 | 0.24842209 |
| 130 | RPS6KC1 | 0.24821703 |
| 131 | RPS6KL1 | 0.24821703 |
| 132 | TRPM7 | 0.24687993 |
| 133 | CAMK4 | 0.24122189 |
| 134 | STK11 | 0.23785520 |
| 135 | DYRK1B | 0.23610582 |
| 136 | IRAK1 | 0.21867593 |
| 137 | HIPK2 | 0.21674550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.33070842 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.27542101 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.19259613 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.72864508 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.66620731 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.62052295 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.53880670 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.51716340 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.35381134 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.32704122 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.20687590 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.18857077 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.17355926 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.13891282 |
| 15 | Measles_Homo sapiens_hsa05162 | 2.11974329 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.06570395 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 2.02096801 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.97561973 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96484547 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.94507535 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.76640159 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.76392112 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73306239 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71335426 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.70973137 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.69933100 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.68475226 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.67483072 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 1.65545508 |
| 30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.61411690 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.60981869 |
| 32 | Salmonella infection_Homo sapiens_hsa05132 | 1.59421596 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57071354 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.55660813 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.52322199 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49908112 |
| 37 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.48550899 |
| 38 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.48376917 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.39003689 |
| 40 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38819631 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35513700 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.32519029 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 1.32293248 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31676261 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27707456 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.21910355 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18228874 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17763098 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04887511 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.03312905 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 1.03048436 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.00382042 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00212514 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98276765 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92660335 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81598826 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79929344 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.79750625 |
| 59 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.79144110 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77222382 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72397922 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72080995 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.70625632 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69465320 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65212301 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.62704801 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.61373683 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60703284 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59599330 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59080032 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58317104 |
| 72 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58000804 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54131561 |
| 74 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.52437420 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51351856 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50914198 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50065533 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49269310 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48579656 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46005491 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40706076 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39163541 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38335226 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37212819 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35847447 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34271985 |
| 87 | Proteasome_Homo sapiens_hsa03050 | 0.32554609 |
| 88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.31814162 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29980700 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29367211 |
| 91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.29213598 |
| 92 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.28313870 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27568485 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25472831 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.24780341 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.24738688 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24213680 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22779071 |
| 99 | * Alcoholism_Homo sapiens_hsa05034 | 0.22511519 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.21693210 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.21586313 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.21584033 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.20718149 |
| 104 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.20654852 |
| 105 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.18917640 |
| 106 | * Morphine addiction_Homo sapiens_hsa05032 | 0.18576952 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.17857032 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.17838517 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.17345530 |
| 110 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.17064986 |
| 111 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.14499764 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.14018384 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.12879791 |
| 114 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.12591540 |
| 115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.10585115 |
| 116 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.09909103 |
| 117 | Bladder cancer_Homo sapiens_hsa05219 | 0.09258864 |
| 118 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.08859205 |
| 119 | Ribosome_Homo sapiens_hsa03010 | 0.08127036 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.07384362 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.06711828 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.06652553 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.05901432 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.04752415 |
| 125 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0260750 |
| 126 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0032185 |

